Evidence map›Paper›PMID 27225235›Full record

ReviewInternational journal of hematology2016

Radiation therapy for primary breast lymphoma in male gynecomastia: a rare case report and review of the literature.

Naoya Ishibashi, Masaharu Hata, Takao Mochizuki, Kogi Ogawa, Hiroaki Sugiura, Yoshinori Takekawa, Toshiya Maebayashi, Takuya Aizawa, Masakuni Sakaguchi, Osamu Abe

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in International journal of hematology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. A Case of ALK-Positive Anaplastic Large Cell Lymphoma of the Male Breast.International medical case reports journal · 2023
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Naoya IshibashiDepartment of Radiology, Nihon University School of Medicine, 30-1 Oyaguchi Kami-cho Itabashi-ku, Tokyo, 173-8610, Japan. ishibashi.naoya@nihon-u.ac.jp.
Masaharu HataDivision of Radiation Oncology, Department of Oncology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
Takao MochizukiDepartment of Radiology, Yokosuka City Hospital, Yokosuka, Kanagawa, Japan.
Kogi OgawaDepartment of Hematology, Yokosuka City Hospital, Yokosuka, Kanagawa, Japan.
Hiroaki SugiuraDepartment of Surgery, Yokosuka City Hospital, Yokosuka, Kanagawa, Japan.
Yoshinori TakekawaDepartment of Pathology, Yokosuka City Hospital, Yokosuka, Kanagawa, Japan.
Toshiya MaebayashiDepartment of Radiology, Nihon University School of Medicine, 30-1 Oyaguchi Kami-cho Itabashi-ku, Tokyo, 173-8610, Japan.
Takuya AizawaDepartment of Radiology, Nihon University School of Medicine, 30-1 Oyaguchi Kami-cho Itabashi-ku, Tokyo, 173-8610, Japan.
Masakuni SakaguchiDepartment of Radiology, Nihon University School of Medicine, 30-1 Oyaguchi Kami-cho Itabashi-ku, Tokyo, 173-8610, Japan.
Osamu AbeDepartment of Radiology, Nihon University School of Medicine, 30-1 Oyaguchi Kami-cho Itabashi-ku, Tokyo, 173-8610, Japan.
Hiratsuka City Hospital · JPNihon University · JPNihon University Itabashi Hospital · JPYokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary breast lymphoma is a rare type of non-Hodgkin lymphoma and usually affects women, although a few cases have been reported in men. Chemotherapy and radiation therapy, or a combination of both, are frequently administered for treatment of primary breast lymphoma, as local control by surgical resection is poor. No standard therapy has been established, and the optimal radiation dose and irradiation field for male patients are unknown. The present report describes a 75-year-old man with bilateral cirrhosis-induced gynecomastia who was diagnosed with primary breast lymphoma; specifically, diffuse large B-cell lymphoma. Because of his hepatic dysfunction, he was treated with radiation therapy alone. Radiation therapy was followed by eight cycles of rituximab monotherapy. Clinical response was good, with no signs of relapse. Clinicians may benefit from knowledge regarding effective treatment of primary breast lymphoma in male patients, which has been rarely reported owing to the low incidence of this condition. The outcome in the present case may help to establish effective treatment guidelines in similar cases.

Indexed as

AgedBreast Neoplasms, MaleCombined Modality TherapyGynecomastiaHumansLymphoma, Large B-Cell, DiffuseMaleRituximabTreatment OutcomeRituximabGynecomastiaMale breast lymphomaPrimary breast lymphomaRadiation therapy

Identifiers

PMID27225235
OpenAlexW2399680147

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.